← United States · Coverage record
US · SEC FORM 4
Parabilis Medicines, Inc.
PBLS · Nasdaq · CIK 0001657677 · Healthcare · Biotechnology
INSIDER SIGNAL
3 buyers · 14 purchase transaction lines · $441.4M gross purchase
WHY THIS SIGNAL?
Score anatomy
Each bar shows the contribution to the current score; the weights and formula stay unchanged.
What is holding the score back?
- ⚠ Cluster breadth is moderate · 3 insider(s), not 4+
- ⚠ Role scores low · most senior buyer: TenPercentOwner (CEO, chair and 10% owners score lowest)
- ⚠ Purchase activity is becoming less recent
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 ranks qualifying equity purchases under the current 180-day rules. The score is a research priority, not a return forecast or probability. Backtests have not shown that a higher US score is followed by better returns.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
—
Purchase breadth & concentration
Roles in the peak window: Director, Director; Director,TenPercentOwner, TenPercentOwner. Concentration uses priced qualifying P lines only and does not change the saved score.
SIGNAL HISTORY
Latest recorded score
- 72.4
- 72.4
- 72.4
- 72.3
- 72.2
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.
Price performance
- 1M
- -24.3%
- 3M
- -7.3%
- 6M
- —
- 12M
- —
Volatility & liquidity
- Volatility
- 69.6%
- Beta
- —
- Avg daily value
- USD 19.2M
Valuation
- Market cap
- —
- P/E
- —
Fundamentals
- Profit margin
- —
- ROE
- —
- Industry
- Biotechnology
Market data
Price data up to: 2026-10-11 · Price source: OpenBB/yfinance; volume from price cache (yfinance) · Status: PASS
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 8,261,483
- Previous report
- 6,092,212
- Avg daily volume
- 1,707,144
- Days to cover
- 4.8
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-07-22 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; Shah Rajeev M. | Purchase (P) | Voting Common Stock | 47,250 | USD 29.77 | USD 1,406,632 | SEC filing ↗ |
| 2026-07-21 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; Shah Rajeev M. | Purchase (P) | Voting Common Stock | 65,923 | USD 29.25 | USD 1,928,032 | SEC filing ↗ |
| 2026-07-20 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; Shah Rajeev M. | Purchase (P) | Voting Common Stock | 131,420 | USD 27.28 | USD 3,584,887 | SEC filing ↗ |
| 2026-06-15 | SEBULSKY ALAN | Purchase (P) | Common Stock | 9,065 | USD 26.49 | USD 240,162 | SEC filing ↗ |
| 2026-06-12 | SEBULSKY ALAN | Purchase (P) | Common Stock | 8,435 | USD 27.67 | USD 233,396 | SEC filing ↗ |
| 2026-06-11 | Levy Guy; Soleus Capital Group, LLC; Soleus Capital Management, L.P.; Soleus Capital Master Fund, L.P.; Soleus Capital, LLC; Soleus GP, LLC; Soleus PE GP III, LLC; Soleus Private Equity Fund III, L.P.; Soleus Private Equity GP III, LLC | Purchase (P) | Common Stock, par value $0.0001 per share | 500,000 | USD 20.00 | USD 10,000,000 | SEC filing ↗ |
| 2026-06-11 | SEBULSKY ALAN | Purchase (P) | Common Stock | 12,500 | USD 20.00 | USD 250,000 | SEC filing ↗ |
| 2026-06-11 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; Shah Rajeev M. | Purchase (P) | Voting Common Stock | 21,188,750 | USD 20.00 | USD 423,775,000 | SEC filing ↗ |
Form 4 evidence
25 transaction lines in the latest 365-day window; 25 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-07-22 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; Shah Rajeev M. | Purchase (P) | Voting Common Stock | 47,250 | USD 29.77 | USD 1,406,632 | SEC filing ↗ |
| 2026-07-21 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; Shah Rajeev M. | Purchase (P) | Voting Common Stock | 65,923 | USD 29.25 | USD 1,928,032 | SEC filing ↗ |
| 2026-07-20 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; Shah Rajeev M. | Purchase (P) | Voting Common Stock | 131,420 | USD 27.28 | USD 3,584,887 | SEC filing ↗ |
Show recent Form 4 evidence (13 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-07-22 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; Shah Rajeev M. | Purchase (P) | Voting Common Stock | 47,250 | USD 29.77 | USD 1,406,632 | SEC filing ↗ |
| 2026-07-21 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; Shah Rajeev M. | Purchase (P) | Voting Common Stock | 65,923 | USD 29.25 | USD 1,928,032 | SEC filing ↗ |
| 2026-07-20 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; Shah Rajeev M. | Purchase (P) | Voting Common Stock | 131,420 | USD 27.28 | USD 3,584,887 | SEC filing ↗ |
| 2026-06-15 | SEBULSKY ALAN | Purchase (P) | Common Stock | 9,065 | USD 26.49 | USD 240,162 | SEC filing ↗ |
| 2026-06-12 | SEBULSKY ALAN | Purchase (P) | Common Stock | 8,435 | USD 27.67 | USD 233,396 | SEC filing ↗ |
| 2026-06-11 | Levy Guy; Soleus Capital Group, LLC; Soleus Capital Management, L.P.; Soleus Capital Master Fund, L.P.; Soleus Capital, LLC; Soleus GP, LLC; Soleus PE GP III, LLC; Soleus Private Equity Fund III, L.P.; Soleus Private Equity GP III, LLC | Purchase (P) | Common Stock, par value $0.0001 per share | 500,000 | USD 20.00 | USD 10,000,000 | SEC filing ↗ |
| 2026-06-11 | Levy Guy; Soleus Capital Group, LLC; Soleus Capital Management, L.P.; Soleus Capital Master Fund, L.P.; Soleus Capital, LLC; Soleus GP, LLC; Soleus PE GP III, LLC; Soleus Private Equity Fund III, L.P.; Soleus Private Equity GP III, LLC | C (C) | Common Stock, par value $0.0001 per share | 527,070 | USD 9.48 | USD 4,996,624 | SEC filing ↗ |
| 2026-06-11 | SEBULSKY ALAN | Purchase (P) | Common Stock | 12,500 | USD 20.00 | USD 250,000 | SEC filing ↗ |
| 2026-06-11 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; Shah Rajeev M. | Purchase (P) | Voting Common Stock | 21,188,750 | USD 20.00 | USD 423,775,000 | SEC filing ↗ |
| 2026-06-11 | Kolchinsky Peter; RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund III, L.P.; Shah Rajeev M. | C (C) | Voting Common Stock | 7,744,621 | USD — | USD — | SEC filing ↗ |
| 2026-06-11 | FITZGERALD EDWARD M | C (C) | Common Stock | 14,688 | USD — | USD — | SEC filing ↗ |
| 2026-06-11 | Borisy Alexis | C (C) | Common Stock | 105,414 | USD — | USD — | SEC filing ↗ |
| 2026-06-11 | DEERFIELD MANAGEMENT COMPANY, L.P.; Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt III, L.P.; Deerfield Private Design Fund III, L.P.; Flynn James E | C (C) | Voting Common Stock | 940,352 | USD — | USD — | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | PBLS |
| CIK | 0001657677 |
| Sector | Healthcare |
| Industry | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| Exchange | Nasdaq |
Data coverage
| Local Form 4 history | 25 transaction lines from 2026-06-11 to 2026-07-22 14 P purchase lines · 0 S sale lines · 11 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.